Title: Risk Factors - PanCareSurPass Project HL7 FHIR Implementation Guide v0.2.0

                                                                      0                                                                       1                                                                       2                                                                       3                           4
Official URL: http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-riskfactor-eu-pcsp Official URL: http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-riskfactor-eu-pcsp Official URL: http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-riskfactor-eu-pcsp Official URL: http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-riskfactor-eu-pcsp             Version:  0.2.0
                                                Draft  as of 2024-05-27                                                 Draft  as of 2024-05-27                                                 Draft  as of 2024-05-27                                                 Draft  as of 2024-05-27 Computable Name: RiskFactor

    0                                                           1                                                                                                                   2                                                                                                                   3
 Code                                                      System                                                                                                             Display                                                                                                          Definition
  1.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                              RT to a vol exposing the thyroid gland                                                                              RT to a vol exposing the thyroid gland
  1.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                                 TBI                                                                                                                 TBI
  1.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                   MIBG therapy (I-131 MIBG therapy)                                                                                   MIBG therapy (I-131 MIBG therapy)
  2.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                           RT >= 10 Gy to a vol exposing the breasts                                                                           RT >= 10 Gy to a vol exposing the breasts
  2.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp OR upper abdominal field radiation that can extend above the diaphragm likely exposing breast tissue at a young age OR upper abdominal field radiation that can extend above the diaphragm likely exposing breast tissue at a young age
  3.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                             RT >= 35 Gy to a vol exposing the heart                                                                             RT >= 35 Gy to a vol exposing the heart
  3.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                       Anthracyclines (doxorubicin isotoxic equivalents)>= 250 mg/m2                                                       Anthracyclines (doxorubicin isotoxic equivalents)>= 250 mg/m2
  3.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp           RT >= 15 Gy to a vol exposing the heart AND Anthracyclines (doxorubicin isotoxic equivalents)>= 100 mg/m2           RT >= 15 Gy to a vol exposing the heart AND Anthracyclines (doxorubicin isotoxic equivalents)>= 100 mg/m2
  4.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                   Alkylating agents                                                                                                   Alkylating agents
  4.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                     RT to a vol exposing the testes                                                                                     RT to a vol exposing the testes
  4.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                       Including TBI                                                                                                       Including TBI
  5.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                          RT >=12 Gy to a vol exposing the testicles                                                                          RT >=12 Gy to a vol exposing the testicles
  6.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                            Surgery to the spinal cord, sympathetic nerves or pelvis                                                            Surgery to the spinal cord, sympathetic nerves or pelvis
  6.4 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                         Hypogonadal                                                                                                         Hypogonadal
  7.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                    RT to a vol exposing the ovaries                                                                                    RT to a vol exposing the ovaries
  8.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                 RT >= 30 Gy to a vol exposing the head or the brain                                                                 RT >= 30 Gy to a vol exposing the head or the brain
  8.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                Cisplatin (with or without carboplatin > 1500 mg/m2)                                                                Cisplatin (with or without carboplatin > 1500 mg/m2)
  9.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                   RT to a vol exposing the pancreas                                                                                   RT to a vol exposing the pancreas
 10.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                                HSCT                                                                                                                HSCT
 11.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                         RT to a volume exposing the hypothalamus or pituatary gland                                                         RT to a volume exposing the hypothalamus or pituatary gland
 11.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                    Hypothalamic or pituitary tumour                                                                                    Hypothalamic or pituitary tumour
 11.4 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                 Neurosurgery of the hypothalamus or pituitary gland                                                                 Neurosurgery of the hypothalamus or pituitary gland
 12.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                RT to a vol exposing the kidneys, heart and associated large vessels                                                RT to a vol exposing the kidneys, heart and associated large vessels
 12.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                         Nephrectomy                                                                                                         Nephrectomy
 12.4 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                          Ifosfamide                                                                                                          Ifosfamide
 12.5 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                        Platinium based chemotherapy                                                                                        Platinium based chemotherapy
 12.6 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                         Nitrosureas                                                                                                         Nitrosureas
 12.7 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp        Immunosuppressives treatment and prolonged steroids as anticancer treatment (at least 4 weeks, continuously)        Immunosuppressives treatment and prolonged steroids as anticancer treatment (at least 4 weeks, continuously)
 13.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                            Cranial and/or spinal RT                                                                                            Cranial and/or spinal RT
 13.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                        Methotrexate                                                                                                        Methotrexate
 13.4 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                     Gonadal failure                                                                                                     Gonadal failure
 13.5 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                           Growth hormone deficiency                                                                                           Growth hormone deficiency
 13.6 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                 Prolonged (at least 4 weeks, continuously) corticosteroids as anti-cancer treatment                                 Prolonged (at least 4 weeks, continuously) corticosteroids as anti-cancer treatment
 13.7 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                            HSCT, especially with an history of GVHD                                                                            HSCT, especially with an history of GVHD
 14.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                        High dose RT                                                                                                        High dose RT
 15.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                               Radiotherapy to a vol exposing the HP region >= 30 Gy                                                               Radiotherapy to a vol exposing the HP region >= 30 Gy
 15.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                Surgery near or within the HP region                                                                                Surgery near or within the HP region
 15.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                            CNS tumours near or within the HP region                                                                            CNS tumours near or within the HP region
 16.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                 Radiotherapy to a vol exposing the HP region< 30 Gy                                                                 Radiotherapy to a vol exposing the HP region< 30 Gy
 16.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                     Hydrocephalus or cerebrospinal fluid shunt(Risk factor for GHD)                                                     Hydrocephalus or cerebrospinal fluid shunt(Risk factor for GHD)
 17.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                        Radiotherapy to a vol exposing the HP region                                                                        Radiotherapy to a vol exposing the HP region
 17.5 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                          hydrocephalus or cerebrospinal fluid shunt                                                                          hydrocephalus or cerebrospinal fluid shunt
 19.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                        Radioiodine therapy (I-131 ablation therapy)                                                                        Radioiodine therapy (I-131 ablation therapy)
 19.5 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                      Allogenic HSCT                                                                                                      Allogenic HSCT
 19.6 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                 Total thyroidectomy                                                                                                 Total thyroidectomy
 20.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                        RT to a vol exposing the head, brain or neck                                                                        RT to a vol exposing the head, brain or neck
 21.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                           History of a central nervous system tumor                                                                           History of a central nervous system tumor
 21.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                             RT to a vol exposing the brain ANY DOSE                                                                             RT to a vol exposing the brain ANY DOSE
 21.4 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                       Brain surgery                                                                                                       Brain surgery
 21.5 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                               High dose cytarabine IV (intravenous)                                                                               High dose cytarabine IV (intravenous)
 21.6 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                    High dose MTX IV                                                                                                    High dose MTX IV
 21.7 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                   Any Chemotherapy IT (intrathecal)                                                                                   Any Chemotherapy IT (intrathecal)
 22.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                     Vinca-Alkaloids                                                                                                     Vinca-Alkaloids
 22.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                            Cisplatin or carboplatin                                                                                            Cisplatin or carboplatin
 23.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                       RT to a vol exposing the lens                                                                                       RT to a vol exposing the lens
 24.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                              RT to a vol exposing the eye and orbit                                                                              RT to a vol exposing the eye and orbit
 25.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                          RT to a vol exposing the craniofacial area, especially after high doses and at a young age                          RT to a vol exposing the craniofacial area, especially after high doses and at a young age
 25.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                      Surgery to the face, especially at a young age                                                                      Surgery to the face, especially at a young age
 26.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                Surgery of the spine                                                                                                Surgery of the spine
 26.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                    Surgery of the chest (Does not include CVC pose)                                                                    Surgery of the chest (Does not include CVC pose)
 26.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                      RT to a vol exposing the spine                                                                                      RT to a vol exposing the spine
 26.4 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                   Spinal or paraspinal malignancies                                                                                   Spinal or paraspinal malignancies
 27.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                    Cyclophosphamide                                                                                                    Cyclophosphamide
 27.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                    RT to a vol exposing the bladder                                                                                    RT to a vol exposing the bladder
 27.5 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                          Cystectomy                                                                                                          Cystectomy
 27.6 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                        Hysterectomy                                                                                                        Hysterectomy
 27.7 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                      Pelvic surgery                                                                                                      Pelvic surgery
 27.8 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                 Spinal cord surgery                                                                                                 Spinal cord surgery
 28.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                         RT to a vol exposing the uterus only female                                                                         RT to a vol exposing the uterus only female
 29.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                             RT to a vol exposing the oral cavity or salivary glands                                                             RT to a vol exposing the oral cavity or salivary glands
 29.4 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                        Chemotherapy                                                                                                        Chemotherapy
 30.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                    RT to a vol exposing the gastro-intestinal tract                                                                    RT to a vol exposing the gastro-intestinal tract
 30.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                 Oesophageal surgery                                                                                                 Oesophageal surgery
 30.4 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                   Abdominal surgery                                                                                                   Abdominal surgery
 30.5 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                      With a history of chronic GVHD                                                                                      With a history of chronic GVHD
 31.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                        Anthracyclines (doxorubicin isotoxic equivalents) <100 mg/m2                                                        Anthracyclines (doxorubicin isotoxic equivalents) <100 mg/m2
 32.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                      RT to a vol exposing the lungs                                                                                      RT to a vol exposing the lungs
 32.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                           Bleomycin                                                                                                           Bleomycin
 32.4 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                            Busulfan                                                                                                            Busulfan
 32.5 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                     BCNU Carmustine                                                                                                     BCNU Carmustine
 32.6 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                      CCNU Lomustine                                                                                                      CCNU Lomustine
 32.7 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                    Thoracic surgery                                                                                                    Thoracic surgery
 33.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                  Cisplatin Any dose                                                                                                  Cisplatin Any dose
 33.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                 Ifosfamide Any dose                                                                                                 Ifosfamide Any dose
 33.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                Carboplatin Any dose                                                                                                Carboplatin Any dose
 34.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                   RT to a volume exposing the liver                                                                                   RT to a volume exposing the liver
34.10 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                        Chronic GVHD                                                                                                        Chronic GVHD
34.11 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                       Liver surgery                                                                                                       Liver surgery
 34.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                         HSCT (irrespective of GVHD)                                                                                         HSCT (irrespective of GVHD)
 34.5 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                          Mercaptopurine Thioguanine                                                                                          Mercaptopurine Thioguanine
 34.6 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                        Dactinomycin                                                                                                        Dactinomycin
 34.8 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                             Chronic viral hepatitis                                                                                             Chronic viral hepatitis
 34.9 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                     Sinusoidal obstruction syndrome                                                                                     Sinusoidal obstruction syndrome
 35.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                         HSCT (irrespective of GVHD)                                                                                         HSCT (irrespective of GVHD)
 35.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                Multiple red blood cell transfusions                                                                                Multiple red blood cell transfusions
 36.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                         Splenectomy                                                                                                         Splenectomy
 36.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                            RT >= 10 Gy to a vol exposing the spleen                                                                            RT >= 10 Gy to a vol exposing the spleen
 36.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                Allogenic HSCT (with or without TBI)                                                                                Allogenic HSCT (with or without TBI)
 36.4 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                 Autologus HSCT conditioned with TBI                                                                                 Autologus HSCT conditioned with TBI
 37.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                                Hereditary cancer sd                                                                                                Hereditary cancer sd
 38.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                Any RT including TBI (predominantly in the RT field)                                                                Any RT including TBI (predominantly in the RT field)
 38.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                         HSCT Especially with a history of skin GvHD                                                                         HSCT Especially with a history of skin GvHD
 39.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                           RT to a vol exposing the colon and rectum                                                                           RT to a vol exposing the colon and rectum
 40.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                RT to a vol exposing the oral cavity                                                                                RT to a vol exposing the oral cavity
 41.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                  Anthracyclines and/or Mitoxantrone                                                                                  Anthracyclines and/or Mitoxantrone
 41.3 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                                   Epipodophyllotoxins or autologous                                                                                   Epipodophyllotoxins or autologous
 41.4 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                      Autologous haematopoietic stem cell transplant                                                                      Autologous haematopoietic stem cell transplant
 42.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                     Ciclofosfamide, Ifosfamide (particularly if they have a history of severe hemorrhagic cystitis)                     Ciclofosfamide, Ifosfamide (particularly if they have a history of severe hemorrhagic cystitis)
 45.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                              RT to a vol exposing the head or brain                                                                              RT to a vol exposing the head or brain
 46.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                 RT between 15 and 35 Gy to a vol exposing the heart                                                                 RT between 15 and 35 Gy to a vol exposing the heart
 46.2 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                         Anthracyclines (doxorubicin isotoxic equivalents) between 100 and 250 mg/m2                                         Anthracyclines (doxorubicin isotoxic equivalents) between 100 and 250 mg/m2
 47.1 http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskfactor-eu-pcsp                                                                    RT to a vol exposing the kidney or urinary tract                                                                    RT to a vol exposing the kidney or urinary tract

         0                                                                                                                                                                                           1
     Level A few code lists that FHIR defines are hierarchical - each code is assigned a level.  In this scheme, some codes are under other codes, and imply that the code they are under also applies
    System                                                                                              The source of the definition of the code (when the value set draws in codes defined elsewhere)
      Code                                                                                                                                        The code (used as the code in the resource instance)
   Display                  The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition                                                                                                                                                An explanation of the meaning of the concept
  Comments                                                                                                                                                  Additional notes about how to use the code

